| Scrip Code | 543220 |
|---|---|
| NSE Symbol | MAXHEALTH |
| MSEI Symbol | NOTLISTED |
| ISIN | INE027H01010 |
| Name of company | Max Healthcare Institute Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 30-10-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 23-10-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Medical and Healthcare Services |
| Start date and time of board meeting | 30-10-2026 12:50:00 |
| End date and time of board meeting | 30-10-2026 14:35:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 2,56,921.00 | 4,93,538.00 | |
| Other income | 4,090.00 | 8,142.00 | |
| Total income | 2,61,011.00 | 5,01,680.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 52,194.00 | 1,04,310.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (663.00) | (1,441.00) |
| (d) | Employee benefit expense | 39,931.00 | 78,749.00 |
| (e) | Finance costs | 7,384.00 | 14,484.00 |
| (f) | Depreciation, depletion and amortisation expense | 13,763.00 | 26,929.00 |
| (f) | Other Expenses | ||
| 1 | Professional and consultancy fee | 56,413.00 | 1,08,756.00 |
| 2 | Other Expenses | 37,897.00 | 72,170.00 |
| Total other expenses | 94,310.00 | 1,80,926.00 | |
| Total expenses | 2,06,919.00 | 4,03,957.00 | |
| 3 | Total profit before exceptional items and tax | 54,092.00 | 97,723.00 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 54,092.00 | 97,723.00 |
| 6 | Tax expense | ||
| 7 | Current tax | 9,531.00 | 17,777.00 |
| 8 | Deferred tax | 3,116.00 | 6,205.00 |
| 9 | Total tax expenses | 12,647.00 | 23,982.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 41,445.00 | 73,741.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 41,445.00 | 73,741.00 |
| 17 | Other comprehensive income net of taxes | 790.00 | 309.00 |
| 18 | Total Comprehensive Income for the period | 42,235.00 | 74,050.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 41,494.00 | 73,743.00 | |
| Total profit or loss, attributable to non-controlling interests | (49.00) | (2.00) | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 42,290.00 | 74,057.00 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | (55.00) | (7.00) | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 97,331.00 | 97,331.00 | |
| Face value of equity share capital | 10 | 10 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 4.26 | 7.58 | |
| Diluted earnings (loss) per share from continuing operations | 4.24 | 7.54 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 4.26 | 7.58 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 4.24 | 7.54 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | For notes, kindly refer PDF file of Financial Results available on stock exchanges website viz. www.bseindia.com & www.nseindia.com |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | ||
|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | ||
| Date of end of reporting period | 30-09-2026 | ||
| Whether results are audited or unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 7,76,377.00 | ||
| Capital work-in-progress | 80,451.00 | ||
| Investment property | 466.00 | ||
| Goodwill | 3,68,920.00 | ||
| Other intangible assets | 2,49,928.00 | ||
| Intangible assets under development | 945.00 | ||
| Biological assets other than bearer plants | 0.00 | ||
| Investments accounted for using equity method | 0.00 | ||
| Non-current financial assets | |||
| Non-current investments | 546.00 | ||
| Trade receivables, non-current | 7,348.00 | ||
| Loans, non-current | 83,996.00 | ||
| Other non-current financial assets | |||
| 1 | Other Financial Assets | 23,315.00 | |
| Total of other non-current financial assets | 23,315.00 | ||
| Total non-current financial assets | 1,15,205.00 | ||
| Deferred tax assets (net) | 3,198.00 | ||
| Other non-current assets | |||
| 1 | Income tax assets (net) | 31,522.00 | |
| 2 | Other non-current assets | 35,574.00 | |
| Total of other non-current assets | 67,096.00 | ||
| Total non-current assets | 16,62,586.00 | ||
| 2 | Current assets | ||
| Inventories | 13,181.00 | ||
| Current financial asset | |||
| Current investments | 0.00 | ||
| Trade receivables, current | 1,24,336.00 | ||
| Cash and cash equivalents | 55,671.00 | ||
| Bank balance other than cash and cash equivalents | 1,425.00 | ||
| Loans, current | 987.00 | ||
| Other current financial assets | |||
| Total of other current financial assets | 6,988.00 | ||
| Total current financial assets | 1,89,407.00 | ||
| Current tax assets (net) | 451.00 | ||
| Other current assets | |||
| 1 | Other current assets | 6,587.00 | |
| Total of other current assets | 6,587.00 | ||
| Total current assets | 2,09,626.00 | ||
| 3 | Non-current assets classified as held for sale | 0.00 | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 | |
| Total assets | 18,72,212.00 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 97,331.00 | ||
| Other equity | 10,35,872.00 | ||
| Total equity attributable to owners of parent | 11,33,203.00 | ||
| Non controlling interest | 20,110.00 | ||
| Total equity | 11,53,313.00 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 3,17,095.00 | ||
| Trade payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | ||
| Total Trade payable | 0.00 | ||
| Other non-current financial liabilities | |||
| 1 | Other non-current financial liabilities | 32,277.00 | |
| Total of other non-current financial liabilities | 32,277.00 | ||
| Total non-current financial liabilities | 3,49,372.00 | ||
| Provisions, non-current | 13,916.00 | ||
| Deferred tax liabilities (net) | 82,585.00 | ||
| Deferred government grants, Non-current | |||
| Other non-current liabilities | |||
| 1 | Other non-current liabilities | 23,748.00 | |
| Total of other non-current liabilities | 23,748.00 | ||
| Total non-current liabilities | 4,69,621.00 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 62,408.00 | ||
| Trade payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 1,296.00 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 98,412.00 | ||
| Total Trade payable | 99,708.00 | ||
| Other current financial liabilities | |||
| 1 | Other current financial liabilities | 57,530.00 | |
| Total of other current financial liabilities | 57,530.00 | ||
| Total current financial liabilities | 2,19,646.00 | ||
| Other current liabilities | 17,823.00 | ||
| 1 | Other current liabilities | 17,823.00 | |
| Total of other current liabilities | 17,823.00 | ||
| Provisions, current | 11,809.00 | ||
| Current tax liabilities (Net) | 0.00 | ||
| Deferred government grants, Current | 0.00 | ||
| Total current liabilities | 2,49,278.00 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | ||
| 4 | Regulatory deferral account credit balances and related deferred tax liability | ||
| Total liabilities | 7,18,899.00 | ||
| Total equity and liabilites | 18,72,212.00 | ||
| Disclosure of notes on assets and liabilities | Textual Information(1) | ||
| Textual Information(1) | For notes, kindly refer PDF file of Financial Results available on stock exchanges website viz. www.bseindia.com & www.nseindia.com |
|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-09-2026 | 30-09-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of defined benefit plans | 35.00 | 43.00 |
| Total Amount of items that will not be reclassified to profit and loss | 35.00 | 43.00 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 6.00 | 12.00 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Fair value changes on derivatives designated as cash flow hedge | 1,018.00 | 374.00 |
| 2 | Exchange differences on translation of foreign operation | (1.00) | (2.00) |
| Total Amount of items that will be reclassified to profit and loss | 1,017.00 | 372.00 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 256.00 | 94.00 |
| 5 | Total Other comprehensive income | 790.00 | 309.00 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | ||||
| B | Date of end of reporting period | 30-09-2026 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 97,723.00 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 13,225.00 | |||||
| Adjustments for decrease (increase) in inventories | (1,441.00) | |||||
| Adjustments for decrease (increase) in trade receivables, current | (30,254.00) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (2,513.00) | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | 269.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | 9,432.00 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | (146.00) | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 26,929.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 1,378.00 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 0.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | 17.00 | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 6,519.00 | |||||
| Adjustments for share-based payments | 2,861.00 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | 4,851.00 | |||||
| Other adjustments for non-cash items | 0.00 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 18,089.00 | |||||
| Net cash flows from (used in) operations | 1,15,812.00 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 16,317.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 99,495.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 38,383.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 490.00 | |||||
| Purchase of property, plant and equipment | 58,925.00 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 9,350.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 5,451.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 1,966.00 | |||||
| Net cash flows from (used in) investing activities | (98,751.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 451.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 42,885.00 | |||||
| Repayments of borrowings | 21,301.00 | |||||
| Payments of lease liabilities | 1,475.00 | |||||
| Dividends paid | 19,437.00 | |||||
| Interest paid | 12,702.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (79.00) | |||||
| Net cash flows from (used in) financing activities | (11,658.00) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | (10,914.00) | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 5.00 | |||||
| Net increase (decrease) in cash and cash equivalents | (10,909.00) | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 66,580.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 55,671.00 | |||||